INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845PAB4. A total of 15 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,712,300 | +22.6% | 21,000,000 | 0.0% | 0.01% | +37.5% |
| Q2 2023 | $16,888,196 | -2.7% | 21,000,000 | 0.0% | 0.01% | -11.1% |
| Q1 2023 | $17,363,331 | +10.2% | 21,000,000 | 0.0% | 0.01% | +12.5% |
| Q4 2022 | $15,760,500 | -0.6% | 21,000,000 | 0.0% | 0.01% | -11.1% |
| Q3 2022 | $15,863,000 | +14.2% | 21,000,000 | 0.0% | 0.01% | +28.6% |
| Q2 2022 | $13,885,000 | +8.1% | 21,000,000 | 0.0% | 0.01% | +40.0% |
| Q1 2022 | $12,846,000 | 0.0% | 21,000,000 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $12,846,000 | +0.9% | 21,000,000 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $12,730,000 | -9.6% | 21,000,000 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $14,083,000 | -37.7% | 21,000,000 | -39.1% | 0.01% | -44.4% |
| Q1 2021 | $22,622,000 | +9.2% | 34,500,000 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $20,713,000 | -13.9% | 34,500,000 | 0.0% | 0.01% | -25.0% |
| Q3 2020 | $24,060,000 | -6.2% | 34,500,000 | 0.0% | 0.01% | -7.7% |
| Q2 2020 | $25,648,000 | -14.1% | 34,500,000 | 0.0% | 0.01% | -35.0% |
| Q1 2020 | $29,870,000 | -35.1% | 34,500,000 | 0.0% | 0.02% | -16.7% |
| Q4 2019 | $45,992,000 | +43.4% | 34,500,000 | -2.8% | 0.02% | +41.2% |
| Q3 2019 | $32,083,000 | +4.1% | 35,500,000 | +14.5% | 0.02% | +6.2% |
| Q2 2019 | $30,830,000 | – | 31,000,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 27,943,000 | $20,241,000 | 1.72% |
| Worth Venture Partners, LLC | 1,569,000 | $1,134,000 | 0.56% |
| Context Capital Management, LLC | 1,985,000 | $1,424,000 | 0.55% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 16,703,000 | $12,060,000 | 0.28% |
| CSS LLC/IL | 6,825,000 | $4,985,000 | 0.28% |
| SILVERBACK ASSET MANAGEMENT LLC | 1,500,000 | $1,095,000 | 0.27% |
| Polar Asset Management Partners Inc. | 20,000,000 | $14,452,000 | 0.24% |
| Senvest Management, LLC | 5,000,000 | $3,621,000 | 0.23% |
| FARALLON CAPITAL MANAGEMENT LLC | 25,500,000 | $18,998,000 | 0.15% |
| LINDEN ADVISORS LP | 12,755,000 | $9,258,000 | 0.15% |